Corvus Pharmaceuticals, Inc. CRVS
10.22 USD -0.38 (-3.58%)
As ofNov 17, 2026, 10:54 AM EST
10.16 Day range 10.84
6.39 52-week range 26.95
- YTD
- +32.73%
- 1 year
- +14.70%
News
seekingalpha.com Corvus Pharmaceuticals: Durability, Not Peak Efficacy, Is The Real Product Corvus Pharmaceuticals offers a catalyst-rich, fully funded pipeline, highlighted by soquelitinib's potential for durable remission in atopic dermatitis and PTCL. Soquelitinib's post-treatment…
benzinga.com Corvus Pharma Q3 2026 Earnings Call Transcript Corvus Pharma (NASDAQ:CRVS) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Corvus Pharma Q3 EPS $(0.22), Inline Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.22) per share which met the analyst consensus estimate. This is a 83.33 percent decrease over losses of $(0.12) per share from the same…
